Eisenmenger Syndrome Treatment Includes Regular Check-Ups And Monitoring For Managing The Condition And Preventing Further Complications
Eisenmenger Syndrome Treatment |
Eisenmenger Syndrome is a
life-threatening medical condition. It can have many serious complications,
including a pulmonary valve dissection, cerebral abscess and heart failure. The
disease is fatal. Most people with this condition will die of hemoptysis, a
complication that occurs when blood leaks from the lungs.
Eisenmenger
Syndrome Treatment helps in a condition that affects the
heart and lungs. The syndrome is caused by a congenital heart defect that
causes a hole in the wall of the heart. This hole increases the pressure on the
lungs, and it also damages the blood vessels in the lungs.
A person
with Eisenmenger Syndrome is at high risk for sudden death. Other complications
include heart failure and stroke. Treatment for the condition may include
medication, surgery, or a heart and lung transplant.
Symptoms
of the disease are usually visible before puberty. People with the condition
can live for twenty to fifty years with proper treatment and management.
However, it is possible for the symptoms to become more severe and lead to
permanent lung damage.
Getting a
diagnosis of the condition is the first step in developing a Eisenmenger
Syndrome Treatment plan. Blood tests, physical exams, and heart health
tests are used to determine the status of the disease. If the disease is
detected early, doctors are able to prevent any permanent damage to the lungs.
There are
several different types of medications that are available for patients with
Eisenmenger syndrome. Depending on the severity of the condition, treatment can
vary. These drugs may be used to treat symptoms and control irregular heart
rhythms. However, they can also increase the risk of bleeding and blood clots.
Medications
are the most common Eisenmenger Syndrome Treatment. They may be
prescribed to lower the amount of iron in the body, as well as to help control
the irregular rhythms of the heart. Medication may also be prescribed to
control the blood pressure and make sure that the blood is flowing smoothly.
Alembic
Pharmaceuticals gained approval from the USFDA for marketing of Selexipag in
December 2021. These can be used for treating pulmonary arterial hypertension.
Comments
Post a Comment